Department of Cardiology, Boston Children's Hospital, Boston MA.
Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA.
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):238-246. doi: 10.1097/QAI.0000000000002007.
Disordered bone mineral metabolism and low vitamin D concentrations are associated with cardiovascular abnormalities; few studies have evaluated this relationship in HIV-infected youth.
The Adolescent Master Protocol is a Pediatric HIV/AIDS Cohort Study network study conducted across 14 US sites.
Among perinatally HIV-infected (PHIV) and perinatally HIV-exposed but uninfected (PHEU) youth enrolled in the Adolescent Master Protocol, we evaluated associations of vitamin D [measured as 25-hydroxy-vitamin D (25-OHD)], parathyroid hormone (PTH), calcium, phosphate, and fibroblast growth factor-23 (FGF-23) concentrations with echocardiographic measures of left ventricular (LV) structure, function, and concentrations of NT-proBNP, a biomarker of cardiac damage.
Among 485 participants (305 PHIV and 180 PHEU) with echocardiograms and bone mineralization measures, low 25-OHD (<20 ng/mL) was common among all participants (48% PHIV and 44% PHEU), but elevated PTH (>65 pg/mL) was identified more often among PHIV participants than PHEU participants (9% vs 3%, P = 0.02). After adjusting for HIV status and demographic covariates, both low 25-OHD and elevated PTH were associated with lower mean LV mass z-scores, whereas elevated PTH was associated with higher mean fractional shortening z-scores. Participants with low 25-OHD also had slightly higher mean LV end-systolic wall stress z-scores, but differences were more pronounced in PHEU participants than in PHIV participants. FGF-23 was inversely related to end-diastolic septal thickness, both overall and among PHIV participants.
In this cohort of PHIV and PHEU youth, we observed associations of 25-OHD, PTH, and FGF-23 with both structural and functional cardiac parameters, supporting links between bone mineral metabolism and cardiac status.
骨矿物质代谢紊乱和维生素 D 浓度降低与心血管异常有关;很少有研究评估过 HIV 感染者的这种关系。
青少年主协议是一个在美国 14 个地点进行的儿科 HIV/AIDS 队列研究网络研究。
在青少年主协议中纳入的围生期 HIV 感染(PHIV)和围生期 HIV 暴露但未感染(PHEU)的青年中,我们评估了维生素 D(以 25-羟维生素 D(25-OHD)测量)、甲状旁腺激素(PTH)、钙、磷和成纤维细胞生长因子 23(FGF-23)浓度与左心室(LV)结构、功能和 NT-proBNP 浓度的超声心动图测量值之间的关系,NT-proBNP 是心脏损伤的生物标志物。
在 485 名有超声心动图和骨矿化测量的参与者(305 名 PHIV 和 180 名 PHEU)中,所有参与者(48%的 PHIV 和 44%的 PHEU)中常见低 25-OHD(<20ng/ml),但 PHIV 参与者中比 PHEU 参与者更常出现高 PTH(>65pg/ml)(9%比 3%,P=0.02)。在调整 HIV 状态和人口统计学协变量后,低 25-OHD 和高 PTH 均与较低的平均 LV 质量 z 评分相关,而高 PTH 与较高的平均节段缩短 z 评分相关。低 25-OHD 患者的平均 LV 收缩末期壁应力 z 评分也略高,但在 PHEU 参与者中差异更为明显。FGF-23 与舒张末期室间隔厚度呈负相关,总体上和 PHIV 参与者中也是如此。
在这个 PHIV 和 PHEU 青年队列中,我们观察到 25-OHD、PTH 和 FGF-23 与结构和功能心脏参数之间的关系,支持骨矿物质代谢与心脏状态之间的联系。